Accelerating human
antibody discovery
and development.

Scroll down
Partner

Turning scientific excellence into therapeutic breakthroughs. We will partner with you to deliver innovative solutions from discovery to development.

Get in touch
Scroll down
TherapeuticPotential

Antibodies play a crucial role in protecting us against infectious diseases. We identify precisely tailored antibody candidates with exceptional activity to improve clinical outcomes.

  • Antibody Discovery

    The human immune system is able to make countless antibodies. We will find the right one for your needs.

    Learn more
  • Antibody Design

    Promising antibodies can be optimized. We enhance their performance for therapeutic success.

    Learn more
  • Antibody Development

    Developing monoclonal antibodies into effective medicines is complex. We enable their efficient translation into clinical applications.

    Learn more
Our vision

Transforming discovery into New Therapeutic Solutions

Our team focuses on advancing novel antibody candidates and translating them into effective treatments for patients.

By combining advanced biotechnology with a deep commitment to global health, Togontech aims to effectively provide antibody-based therapies in the fight against infectious diseases.

Meet Togontech

Team Expertise

  • 10

    Patent applications, 4 antibodies licensed.

  • 50

    Years of combined expertise in antibody research, targeting infectious pathogens.

  • 100

    In vivo experiments conducted, including humanised mice.

  • 4,000

    Monoclonal antibodies isolated and characterised.

  • 500,000

    Neutralisation assays performed.

LegacyInspiration

Togo, the lead sled dog during the 1925 serum run, overcame the most difficult obstacles providing life saving antibodies to the people.

His endurance and intelligence were instrumental in the success of the endeavour, embodying the spirit that inspires Togontech’s mission today.

Our Latest News

View all news
News

Togontech Launches Its New Brand Identity and Website

We’re pleased to introduce Togontech’s new brand identity and website, a refreshed digital presence that reflects our mission, our science, and our vision for the future.

News

Broadly Neutralizing Antibody 007 Published in Nature Immunology

Our new Nature Immunology publication introduces 007, a broadly neutralizing HIV-1 antibody with potential for antibody-based therapies and vaccine design.

Visit Link

Shape the Future of Antibody Therapies

PartnershipsDevelopmentOpportunities

From strategic collaborations to innovative research opportunities, we provide the technical precision and agility needed to advance antibody therapeutics. Whether you want to align your pipeline with our platform or join our growing team, let’s transform research into reality.